Timothy Callahan
Medical · Helper, UTNPI 1427064799
Payments from drug & device makers
Across 106 payments — averaging $18.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- AstraZeneca$255
- Amgen$91
- Pfizer$79
- Boehringer Ingelheim$75
- Biohaven Pharmaceutical Holding Company Ltd.$46
- plus $391 from 15 others
What the payments were for
- Food & beverage$1,948100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 53 | $1,012 |
| AstraZeneca | 14 | $255 |
| Amgen | 5 | $91 |
| Pfizer | 5 | $79 |
| Boehringer Ingelheim | 3 | $75 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $46 |
| Novo Nordisk | 3 | $43 |
| Lilly USA, LLC | 3 | $38 |
| Collegium Pharmaceutical, Inc. | 2 | $34 |
| Novartis | 2 | $34 |
| Dexcom, Inc. | 2 | $33 |
| Idorsia Pharmaceuticals US Inc | 2 | $27 |
| Neurocrine Biosciences, Inc. | 1 | $26 |
| Edwards Lifesciences | 1 | $25 |
| Viatris Specialty LLC | 1 | $25 |
| Abbott | 2 | $24 |
| Organon | 1 | $22 |
| Exact Sciences | 1 | $20 |
| Bayer | 1 | $17 |
| Mylan Specialty L.p. | 1 | $15 |
| Clarus Therapeutics Inc. | 1 | $9 |
How this compares
$1,948 in reported general payments places this provider in the 65th percentile of 263 medical providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 43 | $41,718 |
| MounjaroTirzepatide | 26 | $29,185 |
| EliquisApixaban | 33 | $28,532 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 34 | $28,285 |
| TrulicityDulaglutide | 22 | $26,444 |
| Breo ElliptaFluticasone/Vilanterol | 46 | $21,857 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 20 | $17,804 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 22 | $15,103 |
| LinzessLinaclotide | 18 | $14,760 |
| XareltoRivaroxaban | 14 | $10,979 |
| Aimovig AutoinjectorErenumab-Aooe | 13 | $10,387 |
| Tresiba Flextouch U-100Insulin Degludec | 12 | $8,646 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 13 | $7,697 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 35 | $6,255 |
| TradjentaLinagliptin | 11 | $6,046 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity, Humalog | $38 | $57,74561 claims |
| Novo NordiskOzempic | $43 | $41,71843 claims |
| PfizerEliquis | $79 | $28,53233 claims |
| AbbVieLinzess | $1,012 | $14,76018 claims |
| AstraZenecaBreztri Aerosphere | $255 | $7,69713 claims |
| Boehringer IngelheimTradjenta | $75 | $6,04611 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 263 medical providers in Utah.
Other medical in Helper
- Elisa WilcoxSalt Lake City$178K
- Viet leSalt Lake City$65K
- Val WarnerLayton$51K
- Carmelo DiazSalt Lake City$35K
- Shari CombeSalt Lake City$22K
- Kelly MikesellOgden$19K
- Jennifer CoombsSlc$12K
- Brandon HansenRiverton$10K
- Daniel CorryCedar City$10K
- Mark UdySt George$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.